semaglutide breast cancer GLP-1 medications may offer benefits beyond weight loss and diabetes management, including improved outcomes for patients who are obese or have type 2 diabetes, according to new research. The study GLP-1 use linked to lower

are inventors on the patent

When used with insulin or sulfonylureas, semaglutide increases the risk of hypoglycemia

The Pharmaceutical Response: DPP-4 Inhibitors The pharmaceutical industry recognized this limitation and developed DPP-4 inhibitor drugsmedications like sitagliptin (Januvia), saxagliptin (Onglyza), and linagliptin (Tradjenta)

Route of Administration: Oral (Capsules, Tablets, or Liquid)

In this article, we discuss these novel agents in depth and provide the best evidence supporting their use, along with a critical look at their limitations and future directions

Endogenous peptides are produced naturally by the body